Recombinant Lucilia sericata chymotrypsin in a topical hydrogel formulation degrades human wound eschar ex vivo. (2011)
Attributed to:
DPFS Devolved Portfolio (Pilot)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/btpr.587
PubMed Identifier: 21509949
Publication URI: http://europepmc.org/abstract/MED/21509949
Type: Journal Article/Review
Volume: 27
Parent Publication: Biotechnology progress
Issue: 3
ISSN: 1520-6033